Reliable Cervical Cancer ScreeningBy Oncgnostics
Based on available study data, GynTect® provides a clear indication of malignancy status in patients with abnormal Pap smear: In all previous studies, GynTect was able to detect all cancer cases of the cervix (Sensitivity = 100%).
GynTect is rarely positive in cytological normal patients (Specificity = 96.6%). Cancer occurs via the histopathology defined dysplasia CIN1, CIN2 and CIN3. GynTect detection rates for this dysplasia increase continuously. This indicates a prognostic value of the GynTect cancer marker.